New research shows glioblastoma, a deadly brain cancer, erodes the skull and hijacks immune cells, fuelling tumour growth. Advanced imaging reveals increased pro-inflammatory cells and reduced antibody-producing B cells. Bone-protecting drugs may worsen outcomes, highlighting the need for therapies targeting both brain and skull marrow to improve patient survival.